Beta Blockers and Glucose Metabolism in Chronic Heart Failure: Friend or Foe?

Overview

Journal Clin Res Cardiol

Specialty Cardiology & Vascular Diseases

Date 2007 Nov 21

PMID 18026703

Citations 4

Authors

W Doehner

S D Anker

Affiliations

Soon will be listed here.

Citing Articles

Mandatory oral glucose tolerance tests identify more diabetics in stable patients with chronic heart failure: a prospective observational study.

Stevens A, Hansen D, Vandoren V, Westerlaken R, Creemers A, Eijnde B Diabetol Metab Syndr. 2014; 6(1):44.

PMID: 24673860 PMC: 3986692. DOI: 10.1186/1758-5996-6-44.

Why cachexia kills: examining the causality of poor outcomes in wasting conditions.

Kalantar-Zadeh K, Rhee C, Sim J, Stenvinkel P, Anker S, Kovesdy C J Cachexia Sarcopenia Muscle. 2013; 4(2):89-94.

PMID: 23749718 PMC: 3684705. DOI: 10.1007/s13539-013-0111-0.

Individuals at risk of beta-blocker discontinuation: a cohort study in 19,177 Chinese patients.

Wong M, Jiang J, Su X, Wang H, Tang J, Griffiths S Clin Res Cardiol. 2010; 99(5):277-84.

PMID: 20174812 DOI: 10.1007/s00392-010-0114-1.

The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.

Lainscak M, Hodoscek L, Dungen H, Rauchhaus M, Doehner W, Anker S Wien Klin Wochenschr. 2009; 121(9-10):309-13.

PMID: 19562292 DOI: 10.1007/s00508-009-1185-8.

References

Lainscak M, Cleland J, Lenzen M, Follath F, Komajda M, Swedberg K . International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. Eur J Heart Fail. 2006; 9(3):292-9. DOI: 10.1016/j.ejheart.2006.07.007. View

Waagstein F, Hjalmarson A, VARNAUSKAS E, WALLENTIN I . Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975; 37(10):1022-36. PMC: 482914. DOI: 10.1136/hrt.37.10.1022. View

Bakris G, Fonseca V, Katholi R, McGill J, Messerli F, Phillips R . Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004; 292(18):2227-36. DOI: 10.1001/jama.292.18.2227. View

Reil J, Bohm M . The role of heart rate in the development of cardiovascular disease. Clin Res Cardiol. 2007; 96(9):585-92. DOI: 10.1007/s00392-007-0537-5. View

Doehner W, Rauchhaus M, Ponikowski P, Godsland I, von Haehling S, Okonko D . Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol. 2005; 46(6):1019-26. DOI: 10.1016/j.jacc.2005.02.093. View

Springer J, Filippatos G, Akashi Y, Anker S . Prognosis and therapy approaches of cardiac cachexia. Curr Opin Cardiol. 2006; 21(3):229-33. DOI: 10.1097/01.hco.0000221585.94490.09. View

Doehner W, Rauchhaus M, Godsland I, Egerer K, Niebauer J, Sharma R . Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. Int J Cardiol. 2002; 83(1):73-81. DOI: 10.1016/s0167-5273(02)00022-0. View

Swan J, Walton C, Godsland I . Assessment of insulin sensitivity in man: a comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure. Clin Sci (Lond). 1994; 86(3):317-22. DOI: 10.1042/cs0860317. View

Ko D, Hebert P, Coffey C, Curtis J, Foody J, Sedrakyan A . Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. Arch Intern Med. 2004; 164(13):1389-94. DOI: 10.1001/archinte.164.13.1389. View

10.

Bohm M, Werner N, Kindermann M . [Drug treatment of chronic heart failure]. Clin Res Cardiol. 2006; 95 Suppl 4:36-54. DOI: 10.1007/s00392-006-2008-9. View

11.

Regitz-Zagrosek V, Lehmkuhl E, Weickert M . Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol. 2006; 95(3):136-47. DOI: 10.1007/s00392-006-0351-5. View

12.

Lainscak M, Doehner W, Anker S . Metabolic disturbances in chronic heart failure: a case for the "macho" approach with testosterone?!. Eur J Heart Fail. 2006; 9(1):2-3. DOI: 10.1016/j.ejheart.2006.07.006. View

13.

von Haehling S, Doehner W, Anker S . Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res. 2006; 73(2):298-309. DOI: 10.1016/j.cardiores.2006.08.018. View

14.

Lainscak M, Keber I, Anker S . Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study. Int J Cardiol. 2005; 106(3):319-22. DOI: 10.1016/j.ijcard.2005.01.061. View

15.

Ferrua S, Bobbio M, Catalano E, Grassi G, Massobrio N, Pinach S . Does carvedilol impair insulin sensitivity in heart failure patients without diabetes?. J Card Fail. 2005; 11(8):590-4. DOI: 10.1016/j.cardfail.2005.06.431. View

16.

Basat O, Ucak S, Seber S, Oztekin E, Altuntas Y . After myocardial infarction carvedilol improves insulin resistance compared to metoprolol. Clin Res Cardiol. 2006; 95(2):99-104. DOI: 10.1007/s00392-006-0336-4. View

17.

Flather M, Shibata M, Coats A, Van Veldhuisen D, Parkhomenko A, Borbola J . Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005; 26(3):215-25. DOI: 10.1093/eurheartj/ehi115. View

18.

Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M . Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005; 26(11):1115-40. DOI: 10.1093/eurheartj/ehi204. View

19.

Podbregar M, Voga G . Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure. J Card Fail. 2003; 8(6):369-78. DOI: 10.1054/jcaf.2002.130238. View

20.

Doehner W, Anker S, Godsland I . Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure. Horm Metab Res. 2005; 37(2):106-10. DOI: 10.1055/s-2005-861175. View